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Abstract
We previously showed the impairment of insulin-regulated gene expression in the primary
hepatocytes from Zucker fatty (ZF) rats, and its association with alterations of hepatic glu-
cose and lipid metabolism. However, the molecular mechanism is unknown. A preliminary
experiment shows that the expression level of protein kinase C ζ (PKCζ), a member of atypi-
cal PKC family, is higher in the liver and hepatocytes of ZF rats than that of Zucker lean (ZL)
rats. Herein, we intend to investigate the roles of atypical protein kinase C in the regulation
of hepatic gene expression. The insulin-regulated hepatic gene expression was evaluated
in ZL primary hepatocytes treated with atypical PKC recombinant adenoviruses. Recombi-
nant adenovirus-mediated overexpression of PKCζ, or the other atypical PKC member
PKCι/λ, alters the basal and impairs the insulin-regulated expressions of glucokinase, sterol
regulatory element-binding protein 1c, the cytosolic form of phosphoenolpyruvate carboxy-
kinase, the catalytic subunit of glucose 6-phosphatase, and insulin like growth factor-
binding protein 1 in ZL primary hepatocytes. PKCζ or PKCι/λ overexpression also reduces
the protein level of insulin receptor substrate 1, and the insulin-induced phosphorylation of
AKT at Ser473 and Thr308. Additionally, PKCι/λ overexpression impairs the insulin-induced
Prckz expression, indicating the crosstalk between PKCζ and PKCι/λ. We conclude that the
PKCζ expression is elevated in hepatocytes of insulin resistant ZF rats. Overexpressions of
aPKCs in primary hepatocytes impair insulin signal transduction, and in turn, the down-
stream insulin-regulated gene expression. These data suggest that elevation of aPKC ex-
pression may contribute to the hepatic insulin resistance at gene expression level.
Introduction
The normal physiological responses to insulin stimulation in the liver include the increase of
glycolysis and lipogenesis, and the reduction of gluconeogenesis [1,2]. In hepatic parenchymal
cells, insulin initiates a signaling cascade upon binding to its receptor on the cell membrane,
which is followed by the activation of insulin receptor substrates (IRSs) [3]. Tyrosine
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phosphorylation of IRS1/2 leads to the association and activation of phosphatidylinositol
3-kinase (PI3K). PI3K catalyzes the conversion of phosphatidylinositol-4,5-bisphosphate into
phosphatidylinositol-3,4,5-triphosphate. The latter is a lipid messenger that anchors the down-
stream effector proteins, e.g. phosphoinositide dependent protein kinase-1, AKT (also known
as protein kinase B) and atypical protein kinase C (aPKC), to the cell membrane [3]. For its
maximal activation, AKT is phosphorylated by 3-phosphoinositide-dependent kinase 1
(PDK1) at Thr308, and by mammalian target of rapamycin complex 2 (mTORC2) at Ser473
[4]. Replacing either one of them with alanine residue will significantly impair the insulin-
induced AKT activity [5]. The activations of AKT and aPKC differentially regulate the tran-
scription of hepatic genes for glucose and lipid metabolism [6–8]. For example, the activation
of AKT induces the expression of glucokinase (GCK, gene Gck) to promote glycolysis, and sup-
presses the expression of cytosolic form of phosphoenolpyruvate carboxykinase (PEPCK, gene
Pck1) to reduce gluconeogenesis [9]. On the other hand, the insulin-induced expression of ste-
rol-responsive element binding protein 1c (SREBP-1c, gene Srebp-1c) has been attributed to
the activations of AKT [10,11] and aPKC [12,13].
Members of PKC family include classical PKC, novel PKC, and aPKC. Unlike the other two
types of PKC, aPKC does not require diacylglycerol or Ca2+ for activation. PKCz and PKCι/λ
(genes Prkcz and Prkci, respectively) are two current members of the aPKC subfamily. PKCz
shares 70% homology in amino acid sequence with PKCι/λ (PKCι in human; PKCλ in mouse)
[6]. Both PKCz and PKCι/λmediate a variety of physiological events, such as cell polarity es-
tablishment, cell motility, immune response and metabolism [4].
Activation of PKCz or PKCι/λ has been associated with increased lipogenesis and insulin re-
sistance in multiple tissues and organs [6,14]. The aPKC activation seems to regulate the Srebp-
1c transcription and lipogenesis in the mouse liver. For example, in liver-specific PKCλ knock-
out mice, the basal transcript level of Srebp-1c, but not Gck or Pck1, declined by 50% [12]. In
mice with the liver-specific deletion of the regulatory subunit of PI3K, PKCz/λ activity de-
creased in association with the reduction of Srebp-1c expression [8]. On the other hand, the in-
sulin-induced activation of aPKC and subsequent Srebp-1c expression were retained in the
liver of diabetic mice [15,16]. PKCz/λ is also activated in the liver of mice fed a high fat diet,
which is accompanied by the elevated expression of hepatic Srebp-1c [13]. This effect could be
negated by the overexpression of kinase-inactive form of PKCz [13]. All these observations
suggest the role of aPKCs in the regulation of hepatic lipogenesis.
In hepatocytes isolated from individuals with type 2 diabetes, the basal and insulin-induced
activation of PKCι were elevated [17,18]. Treatment of these hepatocytes with PKCι inhibitors
lowered the expression levels of lipogenic, proinflammatory and gluconeogenic enzymes
[17,18]. Moreover, metformin treatment was shown to induce aPKC activities, and increase
lipogenic and gluconeogenic enzyme levels in hepatocytes from non-obese human subjects
[19]. These data collectively suggest that aPKC isoforms are important players in the pathogen-
esis of obesity and type 2 diabetes. However, whether aPKC plays a role in the insulin-regulated
gene expression in hepatocytes is still unclear.
Zucker fatty (ZF) rat is a genetic model of obesity, hypertriglyceridemia and hepatic insulin
resistance [20]. We previously showed that primary hepatocytes from ZF rats fed chow ad libi-
tum exhibited impairment of the insulin-regulated gene expression [21]. Interestingly, the in-
sulin-induced phosphorylation of AKT at Ser473 and Thr308 in primary hepatocytes of ZF
rats was not significantly different from that of Zucker lean (ZL) rats [21]. Therefore, we sys-
temically compared the activation states of other components of insulin signal transduction
pathway between ZL and ZF hepatocytes. Here, we report the differential expression levels of
PKCz in the liver of ZF and ZL rats, and the effects of PKCz and PKCι/λ overexpression on the
insulin-regulated gene expression in primary rat hepatocytes. We demonstrated that
aPKCOverexpression and Hepatic Gene Expression
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overexpression of PKCz or PKCι/λ in ZL primary hepatocytes impaired the insulin-regulated
gene expression.
Materials and Methods
Reagents
The reagents for primary hepatocyte isolation and culture including Medium 199, Dulbecco’s
Modification of Eagle Medium (DMEM), liver perfusion buffer and liver digest buffer were ob-
tained from Invitrogen (Carlsbad, CA). For RNA extraction, RNA STAT-60 was purchased
from TEL-TEST (Friendswood, TX). The reagents for cDNA synthesis and real-time PCR were
obtained from Applied Biosystems (Foster city, CA). All real-time PCR primer sets used in this
study were synthesized by Sigma-Aldrich (St. Louis, MO). Antibodies against β-actin (#4967),
PKCz (#9368), PKCι (#2998), phospho- PKCz/λ (p-PKCz/λ) Thr410/403 (#9378), AKT
(#9272), phospho-AKT (p-AKT) Ser473 (#9271), p-AKT Thr308 (#9275), p-AKT Thr450
(#9267), insulin receptor substrate 1 (IRS1, #2382), fatty acid synthase (FAS, #3189), acetyl
CoA carboxylase (ACC, #3662), phospho-ACC (p-ACC) Ser79 (#3661) used in this study were
purchased from Cell Signaling Technology (Danvers, MA). All other reagents and materials
were purchased from Fisher Scientific (Pittsburgh, PA) unless described otherwise.
Animals and diets
Zucker rats were bred and housed under constant temperature and humidity in the animal fa-
cility on a 12-hour light-dark cycle. Male ZL (fa/+ or +/+) or ZF (fa/fa) rats at weaning (3
weeks old) were kept on Teklad rodent chow ad libitum (#8640, Harlan Laboratories, India-
napolis, IN) for 8 weeks before liver tissue collection and primary hepatocyte isolation. All pro-
cedures were approved by the Institutional Animal Care and Use Committee at the University
of Tennessee at Knoxville (Protocols #1256, 1642 and 1863).
Liver tissue collection, total protein preparation and total RNA extraction
The rat was euthanized by primary carbon dioxide asphyxiation, and then secondary cervical
dislocation according to regulations. The procedure for liver tissue collection was reported else-
where [21,22]. In brief, a 10ml syringe with a 21G × 1½" hypodermic needle was used to drain
blood from the liver via the inferior vena cava. The liver was excised, sliced, then snap-frozen
in liquid nitrogen, and store at -80°C before further analysis. A small portion of the liver tissue
was homogenized in 10 volumes of cold whole-cell lysis buffer (1% Triton X-100, 10% glycerol,
1% IGEPAL CA-630, 50mMHepes, protease inhibitors, pH 8.0), and then centrifuged to re-
move insoluble matters [21,22]. The protein concentration of the supernatant was determined
with PIERCE BCA protein assay kit. Another small portion of the liver tissue was homogenized
in 10 volumes of cold STAT-60. Total RNA was extracted according to the
manufacturer instructions.
Cultures of primary hepatocytes and 293 HEK cells
The primary hepatocytes were isolated according to published methods [23]. Isolated hepato-
cytes were seeded on 60-mm collagen type I coated dishes at 2×106 cells per dish and incubated
in DMEM (4.5g/L glucose, 8% FBS, 1% penicillin/streptomycin) for 3 hours to allow cell at-
tachment. The attached primary hepatocytes were washed once with PBS and pretreated in me-
dium A (Medium 199 with 100nM dexamethasone, 100nM 3,3’,5-triiodo-L-thyronine, 1nM
insulin, and 1% penicillin/streptomycin) for 16–18 hours. HEK 293 cells were seeded and kept
in DMEM containing 4.5g/L glucose, 4% FBS, 1% penicillin/streptomycin [23].
aPKCOverexpression and Hepatic Gene Expression
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Cloning of the rat Prkci cDNA and subcloning of the rat Prkcz cDNA
Based upon the rat PrkcimRNA sequence (GenBank: EU517502.1), sense 5’-ATC CCC TCA
GCC TCC AGC GG-3’ and antisense 5’-ACT GTG ACC GGG CTA ACG GT-3’ primers were
designed using Primer-BLAST tools from the National Center Biotechnology Information. For
the complete coding sequence of rat Prkci cDNA, PCR was carried out using cDNA derived
from total RNA of ZL primary hepatocyte as the template. For subcloning of rat Prkcz,
pEYFP-N1 vector containing its complete coding sequence (generous gift from Dr. Ralf
Kubitz) was used as the template for the PCR amplification of Prkcz with sense primer 5’-
ACC TCG AGA TGC CCA GCA GGA CCG AC-3’ and antisense primer 5’- GTG AAT TCA CAC
GGA CTC CTC AGC AGA C-3’. The amplicons containing the complete coding sequences of
Prkci and Prkcz cDNA sequences were ligated into pCR2.1 vector through TA Cloning Kit
(Invitrogen) according to the manufacturer’s protocol.
Generation of Ad-Prkcz and Ad-Prkci recombinant adenoviruses
The inserts containing the complete coding sequences of Prkcz and Prkci were subcloned into
pACCMV5 vector to make pACCMV5-Prkcz and pACCMV5-Prkci, respectively. To generate
Ad-Prkcz and Ad-Prkci recombinant adenoviruses, pACCMV5 plasmid containing the com-
plete coding sequence of atypical Prkc sequences was co-transfected with JM17 into HEK293
cells using FuGENE
1
6 Transfection Reagent (Roche) according to manufacturer instructions.
After the formation of the viral plaques, the crude lysate was collected and stored at -80°C. The
amplification and purification of adenovirus were carried out according to published protocols
[23]. The optical density (OD) at 260nm of the adenoviral suspension was determined to esti-
mate the plaque forming units (pfu) of the purified recombinant adenoviruses. We used that 1
OD equals to 1 × 1012 pfu/ml. The purified recombinant adenoviruses were stored at -80°C
until being used.
Infection of recombinant adenoviruses and treatments of primary
hepatocytes
In experiments using recombinant adenoviruses, purified Ad-Prkcz and Ad-Prkci were added
in the medium A (5,000 pfu/cell) to allow the overexpression of PKCz and PKCι/λ in the pri-
mary rat hepatocytes during the pretreatment period, respectively. The pretreated hepatocytes
were then washed once with PBS, and treated with medium A containing indicated concentra-
tions of insulin (0nM to 100nM) for 6 hours before total RNA extraction, or for 15 minutes be-
fore whole cell lysate preparation.
RNA extraction and real-time PCR analysis
The methods for total RNA extraction and cDNA synthesis were described elsewhere [21]. The
gene expression level was determined by real-time PCR with respective primer sets, and nor-
malized to the mRNA level of ribosomal gene 36B4. The nucleotide sequences of primer sets
were as follows: Gck, 50-CGA GAT GCT ATC AAG AGG AGA G-30 (forward), 50-TCA CA
T TGG CGG TCT TCA TAG-30 (reverse); Pck1, 50-AGT CAC CAT CAC TTC CTG GAA
GA-30 (forward), 50-GGT GCA GAA TCG CGA GTT G-30 (reverse); Srebp-1c,
50-GGA GCC ATG GAT TGC ACA TT-30 (forward), 50-AGG CCA GGG AAG TCA CTG
TCT-30 (reverse); Pklr, 50-CGT TTG TGC CAC ACA GAT GCT-30 (forward), 50-
CA T TGG CCA CAT CGC TTG TCT-30 (reverse); G6pc, 50-GAC CTC AGG AAC GCC
TTC TAT G-30 (forward), 50-ATT GAT GCC CAC AGT CTC TTG A-30 (reverse);
Igfbp-1, 50-GAT CAC TGA CCT CAA GAA ATG GAA-30 (forward), 50-GCG GCA CGT
aPKCOverexpression and Hepatic Gene Expression
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TAA TCT CTC TAA CA-30 (reverse). The data were presented as either minus Δ cycle
threshold (Ct) or the induction fold (ΔΔCt) for which the control treatment group was arbi-
trarily set as 1.
Immunoblot analysis of proteins
Protein samples (40μg) of the whole cell lysates of primary hepatocytes or liver tissues were re-
solved in 8% SDS polyacrylamide gel, and then transferred to BIO-RAD Immuno-Blot PVDF
membrane (Hercules, CA) as described [23]. Membranes were blocked by 8% non-fat milk,
and then probed with specific antibodies (1:1 000 dilution). After gentle wash, membranes
were incubated with goat anti-rabbit IgG conjugated with horseradish peroxidase (1:5,000 dilu-
tion). After washing, antigen-bound antibody was detected using ECLWestern Blotting Sub-
strate (Thermo Scientific), and subsequently exposure to X-ray films. The films were scanned,
and the images were stored for the densitometry analysis using ImageJ software (NIH). Densi-
tometry data for each protein were normalized to β-actin levels in each sample.
Statistical Analysis
Statistical analyses were performed using SPSS 19.0 software. Student t-test was used to com-
pare the means between two groups. One-way ANOVA with LSD post-hoc test was used to
compare the means among three or more groups. Data were presented as means ± S.E.M. The
number of experiments indicates hepatocyte isolations from different animals. A p value less
than 0.05 is considered statistically significant.
Results
PKCζ expression is elevated in the liver of ZF rats
Fig. 1A shows that, despite the well-reported hepatic insulin resistance, the levels of phospho-
AKT at Ser473 and Thr450 in the liver of ZF rats were higher than that of ZL rats (please see
densitometry analysis in S1 Fig.). The phospho-AKT at Thr308 in the liver tissues could not be
detected in the current experimental condition, probably due to non-maximal activation of
AKT in ad libitum state, relative less AKT protein amount from hepatocytes in the liver tissue
lysate or rapid de-phosphorylation of AKT at Thr308 during the process of euthanasia of the
animals. This observation shows that the AKT phosphorylation at Ser473 and Thr450 in ZF rat
liver tissue is unimpaired, suggesting the consequence of hyperinsulinemia. In addition, ZF rat
liver had higher protein level of FAS, indicating elevation of hepatic lipogenesis.
On the other hand, the protein level of PKCz, but not PKCι/λ, in the liver of ZF rats was
higher than that of ZL rats (Fig. 1A). The level of phospho-PKCz/λ at Thr410/403, which indi-
cated the phosphorylation of both PKCz and PKC ι/λ, was higher in the liver samples of ZF
rats than that of ZL rats (Fig. 1A). The mRNA level of Prkcz, but not that of Prkci, was also ele-
vated in the ZF liver (Fig. 1B). These data collectively demonstrated that the aPKC expression
levels changes with the development of hepatic insulin resistance in the ZF liver.
Short-term insulin treatment did not alter protein levels of total and
phospho-aPKCs in primary rat hepatocytes
Fig. 2 shows that protein levels of FAS, ACC and phospho-ACC at Ser79 in hepatocytes of ZF
rats were higher than that of ZL rats. This result demonstrates that the hepatic lipogenic capa-
bility remains elevated in ZF hepatocytes cultured for 20 hours. Insulin treatment dose-depen-
dently induced the levels of phospho-AKT at Ser473 and Thr308 in ZL and ZF primary
hepatocytes similarly (Fig. 2). The level of phospho-AKT at Thr450, which was insulin-
aPKCOverexpression and Hepatic Gene Expression
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independent, was slightly higher in ZF hepatocytes than in ZL hepatocytes (Fig. 2). These data
demonstrated that the insulin-induced AKT phosphorylation is comparable in both ZL and ZF
rat hepatocytes. The impaired insulin-regulated gene expression in ZF hepatocytes may be
caused by changes in other components of insulin signaling pathway. On the other hand, the
Fig 1. ZF rats fed chow ad libitum had elevation of expression levels of PKCζmRNA and protein in the
liver. (A) Immunoblot analysis of the expression levels of the perspective proteins in the liver of ZL (n = 4) and
ZF rats (n = 4). (B) The mRNA levels of Prkcz and Prcki in the liver of ZL and ZF rats. ZL and ZF rats at
weaning (3 weeks old) were fed chow diet for 8 weeks. Liver samples of rats fed in ad libitum were collected
and subjected to analysis of protein and mRNA levels as described in the Materials and Methods. The data
were presented mean ± SEM of -ΔCt with animal numbers in parenthesis (* indicates p<0.05 for comparing
ZL and ZF using Student’s t-test).
doi:10.1371/journal.pone.0121890.g001
aPKCOverexpression and Hepatic Gene Expression
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15-minute insulin treatment did not significantly induce or suppress the protein levels of PKCz
and PKCι/λ and phospho-PKCz/λ at Thr410/403 in ZL and ZF primary hepatocytes (Fig. 2).
There was a slight induction of the total PKCz when fresh M199 was added. ZF primary hepa-
tocytes had higher level of PKCz than ZL primary hepatocytes (Fig. 2), which was in line with
the finding from the liver tissues (Fig. 1).
Overexpressions of PKCζ and PKCι/λ in ZL primary hepatocytes
To investigate whether elevated aPKC protein levels contribute to the hepatic insulin resistance
at gene expression level, we constructed recombinant adenoviruses Ad-Prkcz and Ad-Prkci for
their overexpressions in ZL primary rat hepatocytes. The expression level of Pckcz or Prkci
mRNA was normalized to that of ribosomal gene 36B4, which was stable across all treatment
groups (S2 Fig.). In hepatocytes transfected with Ad-β-gal, the relative abundance of Prkcz
mRNA (-ΔCt of -7.90) was much lower than that of PrkcimRNA (-ΔCt of -4.20). The overex-
pression fold of Pckcz or Prkci was calculated using their levels in the Ad-β-gal group as 1. Ad-
Prkcz and Ad-Prkci respectively caused overexpressions of PrkczmRNA (-ΔCt of 3.13, ~2 000
fold, Fig. 3A) and PrkcimRNA (-ΔCt of 3.78, ~250 fold, Fig. 3B, ).
Interestingly, 0.1-100nM insulin treatments significantly suppressed the expression levels of
PrkczmRNA by 40–60% in hepatocytes transfected with Ad-Prkci (Fig. 3A, black columns).
Fig 2. Acute insulin treatment did not alter protein levels of total and phospho-aPKCs in primary hepatocytes from ZL and ZF rats. The primary
hepatocytes from ZL and ZF rats (chow diet, 8 weeks) were pre-treated as described in the Materials and Methods for overnight, and then incubated in fresh
medium A with increasing concentrations of insulin (0nM to 100nM) for 15 min. The hepatocyte group remained in pre-treatment medium was indicated by
“C”. Immunoblot analysis with antibodies against the indicated proteins was performed. The figure shows the representative result of three parallel
experiments obtained from three sets of primary hepatocytes independently isolated from ZL and ZF rats fed chow diet ad libitum.
doi:10.1371/journal.pone.0121890.g002
aPKCOverexpression and Hepatic Gene Expression
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On the other hand, in hepatocytes transfected with Ad-Prkcz, the expression levels of Prkci
mRNA in 1-100nM insulin treatment groups were significantly lower than that in hepatocytes
with β-GAL overexpression at the corresponding treatments (Fig. 3B, striped columns, #).
Fig. 4 shows that PKCz, but not PKCι/λ, protein level was overexpressed by ~9.3 folds in he-
patocytes transfected with Ad-Prkcz compared to that with Ad-β-gal. Overexpression of PKCz
did not significantly increase phospho-PKCz/λ Thr410/403 level. Fig. 5 shows that primary rat
hepatocytes transfected with Ad-Prkci manifested ~4.0 fold overexpression of PKCι/λ protein
and increased phosphorylation of PKCz/λ at Thr410/403, compared to that with Ad-β-gal. Un-
fortunately, we tried and failed to develop a method for the determination of activities of PKCz
and PKCƖ/λ using substrates as reported and available antibodies.
Overexpression of PKCζ or PKCι/λ attenuated the insulin signaling
cascade in ZL primary hepatocytes
Fig. 4 shows that the levels of insulin-induced phosphorylation of AKT at Ser473 and Thr308,
and insulin-independent phosphorylation of AKT at Thr450, were diminished in hepatocytes
overexpressing PKCz, but not β-GAL. There was no change of total AKT. The expression levels
of IRS1 were also lowered upon the overexpression of PKCz. Interestingly, based on the densi-
tometry analysis, there was a slight but significant elevation in the levels of PKCι/λ, FAS, ACC
or phospho-ACC at Ser79 in the hepatocytes overexpressing PKCz compared with Ad-β-gal
group (S3 Fig.).
Fig. 5 shows that PKCι/λ overexpression did not significantly change the expression levels
of PKCz and ACC in ZL primary hepatocytes. The levels of FAS and phospho-ACC Ser79 were
marginally but significantly elevated (S4 Fig.). PKCι/λ overexpression did not change the total
Fig 3. Overexpression of PKCζ and PKCι/λ in primary hepatocytes of ZL rats. Primary hepatocytes of ZL rats fed chow for 8 weeks were isolated and
seeded onto dishes as described in the Materials and Methods. Purified Ad-β-gal, Ad-Prkcz and Ad-Prkci were added in medium A during the overnight
pretreatment period to allow the overexpression of β-GAL, PKCζ and PKCι/λ, respectively. The primary hepatocytes were then incubated in fresh medium A
with increasing concentrations of insulin (0 nM to 100 nM) for 6 hours before total RNA extraction. Total RNA was extracted, and then subjected to real-time
PCR analysis. The data were expressed as fold induction. The gene transcript levels from Ad- β-gal infected primary hepatocytes without insulin treatment
were arbitrarily set to 1. (A) The mRNA levels of Prkcz in the ZL primary hepatocytes overexpressing β-GAL, PKCζ and PKCι/λ in response to treatments of
increasing concentrations of insulin (mean ± SEM; n = 4; all p<0.05; a>b for comparing insulin treatment groups in hepatocytes overexpressing PKCζ using
one-way ANOVA; * for comparing fold inductions among three groups at indicated treatments using one-way ANOVA). (B) The mRNA levels of Prkci in the
ZL primary hepatocytes (n = 4) overexpressing β-GAL, PKCζ and PKCι/λ in response to treatments of increasing concentrations of insulin (mean ± SEM;
n = 4; all p<0.05; * and # for comparing fold inductions among three groups at indicated treatments using one-way ANOVA).
doi:10.1371/journal.pone.0121890.g003
aPKCOverexpression and Hepatic Gene Expression
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AKT level compared with Ad-β-gal group. Similar to that in PKCz overexpression groups, the
levels of IRS1, insulin-induced phospho-AKT at Ser473 and Thr308, and insulin-independent
phosphorylation of AKT at Thr450 were significantly decreased in primary rat hepatocytes
overexpressing PKCι/λ in comparison to the Ad-β-gal group. These data collectively demon-
strate that overexpression of aPKC attenuates the activation of insulin signaling cascade in pri-
mary hepatocytes from ZL rats.
Overexpression of PKCζ or PKCι/ζ impaired the expression levels of
insulin-regulated genes in primary hepatocytes from ZL rats
Insulin dose-dependently induced the expression levels of Gck (Fig. 6A) and Srebp-1c (Fig. 6B)
transcripts in Ad-β-gal group. Overexpression of PKCz or PKCι/λ increased the basal levels of
Gck and Srebp-1c in ZL primary hepatocytes. However, overexpression of PKCz or PKCι/λ
abolished the insulin-induced Gck and Srebp-1c expressions in ZL hepatocytes.
Insulin dose-dependently suppressed the expression levels of Pck1 (Fig. 6C), Igfbp-1
(Fig. 6D) and G6pc (Fig. 6E) transcripts in Ad-β-gal group as anticipated. In the absence of in-
sulin, overexpression of PKCz or PKCι/λ increased or reduced the basal expression levels of
Pck1 (Fig. 6C) or Igfbp-1 (Fig. 6D) transcript, respectively. However, the insulin-suppressed
Fig 4. Overexpression of PKCζ attenuated the activation of insulin signaling cascade in primary
hepatocytes of ZL rats. Primary hepatocytes of ZL rats fed chow for 8 weeks were isolated and seeded onto
dishes as described in the Materials and Methods. Purified Ad-β-gal and Ad-Prkcz were added in ZL primary
rat hepatocytes during the overnight pretreatment period to allow the overexpression of β-GAL and PKCζ,
respectively. Cells were then incubated in fresh medium A with increasing concentrations of insulin (0 nM to
100 nM) for 15 min. The whole cell lysates were subjected to immunoblot analysis with antibodies against
indicated proteins. The figure shows the representative result of three parallel experiments obtained from
three sets of animals.
doi:10.1371/journal.pone.0121890.g004
aPKCOverexpression and Hepatic Gene Expression
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expression of Pck1 was abolished, and insulin-suppressed expressions of Igfbp-1 and G6pc were
attenuated in hepatocytes overexpressing PKCz or PKCι/λ, respectively.
Fig. 6F shows that the mRNA levels of Pklr in hepatocytes overexpressing -GAL, PKCz and
PKCι/λ were not affected by insulin. However, the expressions levels of Pklr in 0-1nM insulin
groups were significantly higher in hepatocytes overexpressing PKCz or PKCι/λ than that
overexpressing β-GAL.
Discussion
Here we show that the expression levels of PKCz protein and PrkczmRNA are higher in the
liver of ZF rats than ZL rats. This elevation remains intact in primary hepatocytes that have
been cultured for more than 20 h. Since the insulin-regulated gene expression is impaired in
primary hepatocytes from ZF rats, we hypothesize that the alteration of aPKC expressions may
play a role in this impairment. Therefore, PKCz and PKCι/λ are successfully overexpressed
using recombinant adenoviruses in ZL primary hepatocytes. The adenoviral-mediated overex-
pression of PKCz or PKCι/λ in primary hepatocytes from ZL rats leads to the impairment of
insulin-regulated Gck, Srebp-1c, Pck1, G6pc and Igfbp1 expressions (Fig. 6). Overexpression of
Fig 5. Overexpression of PKCι/λ attenuated the activation of insulin signaling cascade in primary
hepatocytes of ZL rats. Primary hepatocytes of ZL rats fed chow for 8 weeks were isolated and seeded onto
dishes as described in the Materials and Methods. Purified Ad-β-gal and Ad-Prkci were added in ZL primary
rat hepatocytes during the overnight pretreatment period to allow the overexpression of β-GAL and PKCι/λ,
respectively. Cells were then incubated in fresh medium A with increasing concentrations of insulin (0 nM to
100 nM) for 15 min. The whole cell lysates were subjected to immunoblot analysis with antibodies against
indicated proteins. The figure shows the representative result of three parallel experiments obtained from
three sets of animals.
doi:10.1371/journal.pone.0121890.g005
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Fig 6. Overexpression of PKCζ and PKCι/λ impaired the insulin-regulated gene expression in ZL primary rat hepatocytes. Primary hepatocytes of ZL
rats fed chow for 8 weeks were isolated and seeded onto dishes as described in the Materials and Methods. Purified Ad-β-gal, Ad-Prkcz and Ad-Prkci were
added in medium A during the overnight pretreatment period to allow the overexpression of β-GAL, PKCζ and PKCι/λ, respectively. The primary hepatocytes
were then incubated in fresh medium A with increasing concentrations of insulin (0nM to 100nM) for 6 hours. Total RNA was extracted, and subjected to real-
time PCR analysis. The transcript level of each indicated gene in primary hepatocytes transfected with Ad-β-gal in the absence of insulin treatment was
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either PKCz or PKCι/λ is sufficient to alter basal and insulin-regulated gene expression in he-
patocytes from ZL rats.
The impairment of the insulin-regulated gene expression might be attributed to the reduc-
tion of of AKT phosphorylations in cells with overexpression of PKCz or PKCι/λ., Maximal ac-
tivation of AKT needs phosphorylations of AKT at both Ser473 and Thr308 as indicated in [4].
Therefore, detection of its phosphorylation using specific antibodies have been a indicator of
AKT activation status. It was interesting to note that we could not detect phosphorylation of
AKT at Thr308 in the liver tissue lysates of both ZL and ZF rats. Here are the possible reasons.
First, the in vivo activation of AKT may be moderate, not maximized, which allows further reg-
ulation in response to stimuli. Second, there might be relative less AKT protein amount from
hepatocytes in the liver tissue preparations, which requires a larger amount of protein per sam-
ple for the detection. Third, the phosphorylation of AKT at Thr308 in the liver may be rapidly
de-phoshorylated during the time when the animals were euthanized for the collection of tissue
samples. Nevertheless, we demonstrated here that in ZL hepatocytes of Ad-β-gal group, insulin
dose-dependently induces the levels of phospho-AKT (Ser473 and Thr308) and IRS1 protein.
On the other hand, PKCz or PKCι/λ overexpression attenuates the insulin-induced phosphor-
ylation of AKT, and decreases the protein level of IRS1, which suggests a diminished signaling
cascade initiated from IRS1 upon insulin treatment (Figs. 4 and 5). Without insulin treatment,
the expression level of total AKT and p-AKT seem to be not different between the Ad-β-gal
control and aPKCs overexpression groups (Figs. 4 and 5). However, higher mRNA levels of
Gck, Pck1, Srebp-1c and Pklr were observed in the aPKCs overexpression groups compared to
those in the Ad-β-gal control (Fig. 6). This indicates that other mechanisms may contribute to
the elevation of the basal expression of those genes in hepatocytes overexpressing PKCz or
PKCι/λ.
GCK catalyzes the phosphorylation of glucose into glucose-6-phosphate, which is the rate-
limiting step of glycolysis in the liver [24]. The induction of the hepatic Gck expression depends
on the activation of insulin signaling pathway in the liver [11]. PKCz (Fig. 4) or PKCι/λ (Fig. 5)
overexpression diminished phosphorylation of AKT at Ser473 along with the decrease of IRS1
protein expression. It has been reported that aPKCs probably act as negative feedback regula-
tors of insulin signaling pathway by promoting serine phosphorylation and tyrosine de-
phosphorylation of IRS proteins both in vitro and in cell lines [25–27]. Thus, the reduction of
the activation of insulin signaling pathway due to PKCz or PKCι/λ overexpression may impair
the insulin-regulated Gck expression. Additionally, the insulin-induced Gck expression has
been suggested to be mediated by transcription factors, such as hepatocyte nuclear factor 4,
forkhead box protein O1, SREBP-1c, liver x receptor α, and peroxisome proliferator-activated
receptor γ [28–31]. Since the knowledge about the non-kinase activities and endogenous sub-
strates of PKCz or PKCι/λ is limited, it is possible that PKCz or PKCι/λ directly regulate Gck
expression through controlling the activation of certain transcription factors at its promoter,
which increases the Gck basal mRNA level.
PEPCK catalyzes the rate limiting enzymatic reaction in gluconeogenesis, by which oxaloac-
etate is converted into phosphoenolpyruvate [32]. In the liver, the insulin-suppressed Pck1 ex-
pression has been thought to be purportedly mediated through three pathways: (1) the
phosphorylation and inactivation of forkhead box proteins by insulin [33,34]; (2) antagonizing
arbitrarily set to 1 for that gene. The mRNA levels of (A)Gck, (B) Srebp-1c, (C) Pck1, (D) Igfbp-1, (E)G6pc and (F) Pklrwere expressed as fold inductions
(mean ± SEM; n = 4; all p<0.05; a<b, c<d, e>f, g>h, i>j, k>l, m>n, o>p, q>r for comparing the insulin treatment groups of hepatocytes overexpressing Ad-
β-gal, Ad-Prkcz or Ad-Prkci using one-way ANOVA; * for comparing fold inductions among Ad-β-gal, Ad-Prkcz and Ad-Prkci groups at the indicated insulin
concentrations using one-way ANOVA).
doi:10.1371/journal.pone.0121890.g006
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the glucagon-induced PPARγ co-activator 1 expression [35]; (3) the phosphorylation of CREB-
binding protein via aPKCs [36,37]. Interestingly, insulin-induced activation of aPKCs was
shown to suppress Pck1 expression via this phosphorylation of SREBP-binding protein [36].
However, our results show the induction of Pck1 expression upon overexpression of PKCz or
PKCƖ/λ in the absence of insulin. The activities of aPKC isoforms are elevated in the liver of in-
dividuals with type 2 diabetes [17]. Treatment of hepatocytes from these individuals with
aPKC inhibitors decreases the basal transcript levels of gluconeogenic genes [17]. Hepatic in-
hibitors of PKCƖ have been show to correct the metabolic abnormalities in rodents [18]. Here,
aPKCs overexpression not only increases the basal transcript of Pck1mRNA, but also abrogates
the insulin-suppressed Pck1 expression. Additionally, aPKCs overexpression attenuates the in-
sulin-suppressed G6pc expression. Therefore, our data suggest that aPKCs are prominent posi-
tive regulators of hepatic gluconeogenesis.
SREBP-1c is a master regulator of the hepatic expression of lipogenic genes [38]. The insu-
lin-induced Srebp-1c expression requires the activation of PI3K, and the mTORC2-mediated
phosphorylation of AKT at Ser473 [39]. Based on the use of pharmacological inhibitors, the ac-
tivation of mTORC1 downstream of AKT is identified as an indispensible step in the induction
of Srebp-1c [39]. On the other hand, the activation of PI3K subsequently activates aPKC in the
liver, which promotes Srebp-1c expression and lipogenesis [12,13]. Despite the diminished acti-
vation of AKT and the abolished insulin-induced Srebp-1c expression, PKCz or PKCι/λ overex-
pression increases the basal transcript level of Srebp-1c in the primary hepatocytes from ZL rats
(Fig. 6C). Interestingly, PKCz or PKCι/λ overexpression only marginally induced the protein
levels of FAS and ACC (Figs. 4 and 5). One possibility is that the elevation levels of transcripts
might not have been translated in the presence of overexpression of PKCz or PKCι/λ. Alterna-
tively, diminished insulin signaling pathway results in decreased activation of p70 S6-kinase,
which is required for the SREBP-1c processing to generate nuclear SREBP-1c [40]. Moreover,
there might be a lag time between the elevation of Srebp-1cmRNA and the increase of SREBP-
1c protein, and the down-stream targets. Nevertheless, the protein levels of ACC and are main-
tained at a high level in the hepatocytes and liver samples of ZF rats (Figs. 1 and 2), demon-
strating the metabolic changes associated with these insulin-resistant animals. Further
investigations are needed to delineate the sequential events associated with the elevation of the
hepatic lipogenesis upon insulin stimulation and activation of AKT and aPKC isoforms.
It is interesting to note that the PrkczmRNA and PKCz protein, but not that of Prkci
mRNA and PKCι/λ protein levels are elevated in the liver of ZF rats. Insulin at 1nM and up sig-
nificantly induces the expression levels of PrkcimRNA, a process that is blunted in the pres-
ence of PKCz overexpression. On the other hand, insulin does not affect the expression of
PrkczmRNA. Additionally, PKCι/λ overexpression alone does not affect PrkczmRNA expres-
sion. However, PKCι/λ overexpression introduced the insulin-mediated suppression of Prkcz
mRNA expression. These data indicate that there are crosstalks between PKCz and PKCι/λ
pathways, which may mutually regulate the expression of each other at mRNA levels in re-
sponse to hormonal or nutritional stimuli. The alteration of this mutual regulation mechanism
probably is associated with the development of the impairment of insulin signaling cascade.
Further studies are warranted.
It is worth noting that, in ZL primary hepatocytes, the overexpression of aPKCs and the at-
tenuated insulin signaling cascade lead to abolishment of insulin-regulated expression of Gck,
Pck1 and Srebp-1c (Fig. 6). In contrast, ZF rats showed unimpaired phosphorylation of AKT at
Ser473 and Thr450 despite increased PKCz levels (Figs. 1 and 2). This difference may explain
that the insulin-regulated expression of Gck and Pck1 is impaired rather than abolished in ZF
primary hepatocytes [41]. Additionally, in high-fat diet fed mice, increased basal AKT phos-
phorylation was observed in the liver with indication for the development of insulin resistance
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[42]. Additionally, elevated aPKC activity was shown to attenuate AKT-dependent FOXO1
phosphorylation in the liver of diet-induced obesity mice, despite concurrent elevated hepatic
AKT activity [43]. These data collectively suggest that activation statuses of both AKT and
aPKC are critical in the regulation of hepatic insulin sensitivity.
In summary, we have shown that the expression level of PKCz is elevated in insulin-
resistant animals. Overexpression of PKCz or PKCƖ/λ in ZL primary hepatocytes reduces the
activation of AKT probably through the reduction of IRS1 expression, demonstrating the at-
tenuation of the activation of insulin signal pathway. This alteration of the expression levels of
aPKC leads to the impairment of the insulin-regulated gene expression in primary hepatocytes.
Our data demonstrate the critical roles of aPKCs in the regulation of hepatic insulin-sensitivity
at gene expression level, and provide insights into the development of the insulin resistance
and type 2 diabetes.
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